IP Library Granted Patent US 8,444,922
Granted Patent B2
US 8,444,922 · App. 13/148,919 · Granted May 21, 2013

Air purification

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,444,922
App. No.
13/148,919
Granted
May 21, 2013
Kind
B2
Abstract

The present disclosure relates to purification and/or sterilization techniques and devices. Methods and systems are provided herein for removing contaminants from air using a combination of an ionic liquid and a reactive oxygen species.

Claims (11)

1. A method of removing a contaminant from air, the method comprising:

providing a wet filter comprising an ionic liquid;

generating a reactive oxygen species;

dissolving the reactive oxygen species in the ionic liquid; and

flowing contaminated air that comprises a contaminant against the wet filter to allow air within the contaminated air to flow completely through the wet filter while allowing the reactive oxygen species in the ionic liquid to react with the contaminant from the air, thereby removing a contaminant from air.

2. The method of claim 1 , wherein the reactive oxygen species are generated using UV irradiation.

3. The method of claim 1 , wherein the reactive oxygen species are generated using an electrical current.

4. The method of claim 1 , further comprising selecting a voltage to achieve a desired concentration of a reactive oxygen species in the ionic liquid to remove the contaminant from the air.

5. The method of claim 1 , wherein the reactive oxygen species comprises ozone, oxygen radicals, atomic oxygen, O 2 —, hydroxyl radicals, hydrogen peroxide, or any combination thereof.

6. The method of claim 1 , wherein the reactive oxygen species is stable in the ionic liquid for greater than about 60 seconds.

7. The method of claim 1 , wherein the ionic liquid comprises: acetonitrile (MeCN), dimethyl formamide (DMF), dimethyl sulfoxide (DMSO), quaternary ammonium, compounds comprising an imidazolium group, or any combination thereof.

Assignments (1)
SECURITY INTEREST Recorded Jan 29, 2019
From: EMPIRE TECHNOLOGY DEVELOPMENT LLC
To: CRESTLINE DIRECT FINANCE, L.P.
Reel/Frame 048373/0217 →